Literature DB >> 19380029

NUP98-NSD3 fusion gene in radiation-associated myelodysplastic syndrome with t(8;11)(p11;p15) and expression pattern of NSD family genes.

Takeshi Taketani1, Tomohiko Taki, Hideo Nakamura, Masafumi Taniwaki, Junichi Masuda, Yasuhide Hayashi.   

Abstract

Chromosomal 11p15 abnormality of therapy-related myelodysplastic syndrome (t-MDS)-acute myeloid leukemia (AML) is rare. NUP98-NSD3 fusion transcripts have been detected previously in one patient with AML and one patient with t-MDS having t(8;11)(p11;p15). Here we present the case of a 60-year-old man with radiation-associated MDS (r-MDS) carrying chromosome abnormalities, including t(8;11)(p11;p15) and del(1)(p22p32). Fluorescence in situ hybridization analysis demonstrated that the NUP98 gene at 11p15 was split by the translocation. Southern blot analysis of bone marrow cells showed both rearrangements of NUP98 and NSD3 genes. Reverse transcriptase-polymerase chain reaction (RT-PCR) followed by sequence analysis revealed the presence of both NUP98-NSD3 and NSD3-NUP98 fusion transcripts. Expression analysis by RT-PCR showed that NSD3 as well as NSD1 and NSD2 was ubiquitously expressed in leukemic cell lines and Epstein-Barr virus transformed B lymphocyte cell lines derived from the normal adult lymphocytes examined. Two isoforms of NSD3, NSD3S and NSD3L (but not NSD3L2), were expressed in leukemic cell lines and were fused to NUP98 in our patient, suggesting that qualitative change of these two isoforms of NSD3 by fusion with NUP98 might be related to leukemogenesis, although the function of each isoform of the NSD3 gene remains unclear.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19380029     DOI: 10.1016/j.cancergencyto.2008.12.008

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  20 in total

Review 1.  Histone methylation in myelodysplastic syndromes.

Authors:  Yue Wei; Irene Gañán-Gómez; Sophie Salazar-Dimicoli; Sara L McCay; Guillermo Garcia-Manero
Journal:  Epigenomics       Date:  2011-04       Impact factor: 4.778

Review 2.  Understanding the language of Lys36 methylation at histone H3.

Authors:  Eric J Wagner; Phillip B Carpenter
Journal:  Nat Rev Mol Cell Biol       Date:  2012-01-23       Impact factor: 94.444

Review 3.  The Role of Nuclear Receptor-Binding SET Domain Family Histone Lysine Methyltransferases in Cancer.

Authors:  Richard L Bennett; Alok Swaroop; Catalina Troche; Jonathan D Licht
Journal:  Cold Spring Harb Perspect Med       Date:  2017-06-01       Impact factor: 6.915

Review 4.  H3K36 methyltransferases as cancer drug targets: rationale and perspectives for inhibitor development.

Authors:  David S Rogawski; Jolanta Grembecka; Tomasz Cierpicki
Journal:  Future Med Chem       Date:  2016-08-22       Impact factor: 3.808

Review 5.  Gain-of-function mutation of chromatin regulators as a tumorigenic mechanism and an opportunity for therapeutic intervention.

Authors:  Chen Shen; Christopher R Vakoc
Journal:  Curr Opin Oncol       Date:  2015-01       Impact factor: 3.645

6.  Development of mammary hyperplasia, dysplasia, and invasive ductal carcinoma in transgenic mice expressing the 8p11 amplicon oncogene NSD3.

Authors:  Brittany Turner-Ivey; Ericka L Smith; Alex C Rutkovsky; Laura S Spruill; Jamie N Mills; Stephen P Ethier
Journal:  Breast Cancer Res Treat       Date:  2017-05-08       Impact factor: 4.872

Review 7.  Cancer epigenetics: a brief review.

Authors:  Shama Virani; Shami Virani; Justin A Colacino; Jung H Kim; Laura S Rozek
Journal:  ILAR J       Date:  2012

Review 8.  Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and prevention.

Authors:  Xuejiao Tian; Saiyang Zhang; Hong-Min Liu; Yan-Bing Zhang; Christopher A Blair; Dan Mercola; Paolo Sassone-Corsi; Xiaolin Zi
Journal:  Curr Cancer Drug Targets       Date:  2013-06       Impact factor: 3.428

9.  Everybody's welcome: The big tent approach to epigenetic drug discovery.

Authors:  Erin M Green; Or Gozani
Journal:  Drug Discov Today Ther Strateg       Date:  2011-09-20

Review 10.  Histone lysine methyltransferases in biology and disease.

Authors:  Dylan Husmann; Or Gozani
Journal:  Nat Struct Mol Biol       Date:  2019-10-03       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.